Follow the 제넨바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 제넨바이오 has logged 38 reports. The latest transaction was reported on 14 March 2024 (Other). Among the most active insiders: 메리츠증권. The full history is openly available.
38
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
7 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Genenbio is in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biopharmaceutical solutions.